Seen in the most types of human diabetic nephropathy, the activation of the JNK pathway can worsen symptoms and inhibiting the JNK pathway is a therapeutic target for diabetic nephropathy [34]. The gene discussed is MAPK8; the disease is diabetic kidney disease.